Alnylam Pharmaceuticals, Inc. (MM) Stock Price - ALNY

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$43.59
SMALL CAP PRO
Monthly Subscription
for only
$43.59
Canadian Level 1 + USA
Monthly Subscription
for only
$33.59
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Alnylam Pharmaceuticals, Inc. (MM) ALNY NASDAQ Common Stock US02043Q1076
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.00 +0.00% 52.08 - - - 52.08 05:06:37
Bid Price Ask Price Spread Spread % News
49.07 60.95 11.88 19.49% - -
Last Trade Time Type Quantity Stock Price Currency
- - - USD

Alnylam Pharmaceuticals, Inc. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.48B 86.05M $ -410.11M -4.79 0.00 40.8M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.4M $ 0.00 0.00% 37.11k 96.70%

more financials information »

Alnylam Pharmaceuticals, Inc. (MM) News

Date Time Source News Article
3/28/201716:00Business WireAlnylam to Webcast Presentation at 16th Annual Needham..
3/17/201716:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)
3/17/201712:15Business WireThe Medicines Company and Alnylam Pharmaceuticals Report..
3/01/201705:15Business WireAlnylam Receives European Medicines Agency PRIME Designation..
2/28/201708:52Business WireAlnylam Acknowledges Rare Disease Day by Highlighting..
2/27/201716:00Business WireAlnylam to Webcast Presentations at Upcoming March Investor..
2/15/201717:09Edgar (US Regulatory)Annual Report (10-k)

Historical ALNY Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week54.2954.59650.770.0000573k1M891k-2.21-4.07%
1 Month52.7960.4149.000.0000236k5M1M-0.71-1.34%
3 Months38.5960.4135.980.0000236k5M999k13.4934.96%
6 Months78.2278.8731.380.0000236k17M1M-26.14-33.42%
1 Year60.5080.1131.380.0000236k17M1M-8.42-13.92%
3 Years67.94140.0031.380.0000017M854k-15.86-23.34%
5 Years10.68140.009.510.0000017M730k41.40387.64%

Alnylam Pharmaceuticals, Inc. (MM) Description

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170329 11:09:41